GPC3 and neoplasm: For example, Glypican-3 (GPC3)-targeted CAR-NK cells exhibited specific cytotoxicity against GPC3-expressing hepatocellular carcinoma cells in both in vitro and in vivo models, showing resistance to immunosuppressive factors in the tumor microenvironment (39).